MedTrace Logo

Clinical Study Evaluating Wound Closure With Endoform™ and Symphony™

NCT06035523 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2026-01-28

No results posted yet for this study

Summary

Study will evaluate the performance and safety of Endoform™ Natural and Endoform™ Antimicrobial in conjunction with Symphony™ in the treatment of chronic non-healing diabetic foot ulcers after 12 weeks of treatment.

Conditions

  • Wound Healing
  • Diabetic Foot
  • Chronic Foot Ulcer
  • Foot Ulcer

Interventions

DEVICE

Endoform™ Antibacterial

Application of Endoform™ Antibacterial

DEVICE

Endoform™ Natural

Application of Endoform™ Natural

DEVICE

Symphony™

Application of Symphony™

Sponsors & Collaborators

  • Professional Education and Research Institute

    collaborator OTHER

  • Aroa Biosurgery Limited

    lead INDUSTRY

Principal Investigators

  • David Armstrong, DPM, MD PhD · Keck School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-29
Primary Completion
2025-08-30
Completion
2025-08-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06035523 on ClinicalTrials.gov